Sanofi SG&A Expenses 2012-2026 | SNY

Sanofi sg&a expenses for the twelve months ending March 31, 2026 were $11.180B, a 18.31% increase year-over-year.

  • Sanofi annual sg&a expenses for 2025 were $10.797B, a 8.65% increase from 2024.
  • Sanofi annual sg&a expenses for 2024 were $9.937B, a 14.13% decline from 2023.
  • Sanofi annual sg&a expenses for 2023 were $11.572B, a 4.68% increase from 2022.

Sanofi SG&A Expenses 2012-2026 | SNY

  • Sanofi annual sg&a expenses for 2025 were $10.797B, a 8.65% increase from 2024.
  • Sanofi annual sg&a expenses for 2024 were $9.937B, a 14.13% decline from 2023.
  • Sanofi annual sg&a expenses for 2023 were $11.572B, a 4.68% increase from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B